• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜血管性增生肿瘤:334 例原发性与继发性肿瘤的临床对比特征。

Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases.

机构信息

The OcularOncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

JAMA Ophthalmol. 2013 Mar;131(3):328-34. doi: 10.1001/2013.jamaophthalmol.524.

DOI:10.1001/2013.jamaophthalmol.524
PMID:23494037
Abstract

OBJECTIVE

To compare the clinical features of primary vs secondary retinal vasoproliferative tumors (VPTs).

METHODS

Retrospective case series of 334 tumors in 295 eyes of 275 patients.

RESULTS

Of 275 patients with VPT, 41% (n = 113) were male and 59% (n = 162) were female, with a mean age of 44 years at presentation. Primary VPT occurred in 80% (n = 219) and secondary VPT, in 20% (n = 56) of patients. Secondary VPT (n = 67) occurred in eyes with retinitis pigmentosa (n = 15, 22%), pars planitis (n = 14, 21%), Coats disease (n = 11, 16%), previous retinal detachment surgery (n = 8, 12%), idiopathic peripheral retinal vasculitis (n = 4, 6%), familial exudative vitreoretinopathy (n = 3, 4%), and others (n = 12, 18%). The mean interval between diagnosis of underlying ocular condition and secondary VPT was 160 months. Statistically significant differences (P < .05) in clinical features (primary vs secondary VPTs) included mean age at presentation (46 vs 38 years), visual symptoms (74% vs 87%), poor visual acuity worse than 20/200 (15% vs 28%), bilaterality (4% vs 20%), multifocality (5% vs 15%), postequatorial tumor location (20% vs 33%), tumor basal dimension (6 vs 7 mm), anterior chamber cells (16% vs 30%), and vitreous cells (19% vs 48%).

CONCLUSIONS

Retinal vasoproliferative tumor can be primary (80%) or secondary (20%). Compared with primary VPT, secondary VPT is more often bilateral, multiple, and larger and occurs at an earlier age associated with poorer visual acuity.

摘要

目的

比较原发性与继发性视网膜血管性肿瘤(VPT)的临床特征。

方法

对 275 例患者的 295 只眼中的 334 个肿瘤进行回顾性病例系列研究。

结果

275 例 VPT 患者中,男性占 41%(n=113),女性占 59%(n=162),发病时的平均年龄为 44 岁。原发性 VPT 占 80%(n=219),继发性 VPT 占 20%(n=56)。继发性 VPT(n=67)发生于视网膜色素变性(n=15,22%)、中间葡萄膜炎(n=14,21%)、Coats 病(n=11,16%)、既往视网膜脱离手术(n=8,12%)、特发性周边视网膜血管炎(n=4,6%)、家族渗出性玻璃体视网膜病变(n=3,4%)和其他(n=12,18%)患者的眼中。继发于基础眼病与继发性 VPT 之间的平均间隔时间为 160 个月。在临床特征(原发性与继发性 VPT)方面存在统计学显著差异(P<0.05),包括发病时的平均年龄(46 岁 vs 38 岁)、视觉症状(74% vs 87%)、视力低于 20/200(15% vs 28%)、双眼性(4% vs 20%)、多发性(5% vs 15%)、后极部肿瘤位置(20% vs 33%)、肿瘤基底直径(6 毫米 vs 7 毫米)、前房细胞(16% vs 30%)和玻璃体细胞(19% vs 48%)。

结论

视网膜血管性肿瘤可为原发性(80%)或继发性(20%)。与原发性 VPT 相比,继发性 VPT 更常为双侧、多发性和更大,并发生于更年轻的患者,视力更差。

相似文献

1
Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases.视网膜血管性增生肿瘤:334 例原发性与继发性肿瘤的临床对比特征。
JAMA Ophthalmol. 2013 Mar;131(3):328-34. doi: 10.1001/2013.jamaophthalmol.524.
2
Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants.印度参与者的血管性增生性肿瘤的临床特征和治疗结果。
Indian J Ophthalmol. 2018 Feb;66(2):246-251. doi: 10.4103/ijo.IJO_210_17.
3
Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases.冷冻疗法诱导的视网膜前膜松解与视网膜血管增生性肿瘤:16例分析
Retina. 2014 Aug;34(8):1644-50. doi: 10.1097/IAE.0000000000000137.
4
Retinal vasoproliferative tumors in ocular conditions of childhood.儿童眼部疾病中的视网膜血管增生性肿瘤。
J AAPOS. 2012 Feb;16(1):6-9. doi: 10.1016/j.jaapos.2011.10.010.
5
Retinal vasoproliferative tumors in 6 patients with neurofibromatosis type 1.6 例神经纤维瘤病 1 型患者的视网膜血管性增生性肿瘤。
JAMA Ophthalmol. 2014 Feb;132(2):190-6. doi: 10.1001/jamaophthalmol.2013.6281.
6
Rhegmatogenous retinal detachment after block excision of epithelial implantation cysts and tumors of the anterior uvea.前葡萄膜上皮植入性囊肿和肿瘤整块切除术后的孔源性视网膜脱离
Ophthalmology. 1999 Oct;106(10):1942-6. doi: 10.1016/S0161-6420(99)90405-0.
7
Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes.125碘敷贴放疗治疗30只眼视网膜血管增生性肿瘤
Arch Ophthalmol. 2008 Sep;126(9):1245-51. doi: 10.1001/archopht.126.9.1245.
8
Retinal metastasis from systemic cancer in 8 cases.8例系统性癌症的视网膜转移。
JAMA Ophthalmol. 2014 Nov;132(11):1303-8. doi: 10.1001/jamaophthalmol.2014.2406.
9
Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity.获得性血管增生性视网膜肿瘤:早产儿视网膜病变的晚期后遗症。
Arch Ophthalmol. 2011 Sep;129(9):1234-5. doi: 10.1001/archophthalmol.2011.265.
10
VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS.中间葡萄膜炎相关的血管性肿瘤。
Retina. 2020 Sep;40(9):1765-1773. doi: 10.1097/IAE.0000000000002656.

引用本文的文献

1
Outcomes of Vitrectomy for Macular Pathologies Associated with Idiopathic Vasoproliferative Retinal Tumor.特发性血管增生性视网膜肿瘤相关黄斑病变的玻璃体切除术结果
J Clin Med. 2025 Sep 3;14(17):6221. doi: 10.3390/jcm14176221.
2
Genotypic Distribution and Clinical Correlations in Familial Exudative Vitreoretinopathy: A Single-Center Study.家族性渗出性玻璃体视网膜病变的基因型分布及临床相关性:一项单中心研究
Ophthalmol Sci. 2025 Mar 28;5(5):100782. doi: 10.1016/j.xops.2025.100782. eCollection 2025 Sep-Oct.
3
Bilateral Vasoproliferative Tumors in Usher Syndrome.
Usher综合征中的双侧血管增生性肿瘤。
Case Rep Ophthalmol. 2025 Mar 25;16(1):261-266. doi: 10.1159/000542415. eCollection 2025 Jan-Dec.
4
Vasoproliferative Retinal Tumors: Manifestations, Management, and Outcomes in a Case Series.增殖性视网膜肿瘤:病例系列中的表现、管理及结果
Case Rep Ophthalmol. 2024 Dec 16;16(1):27-36. doi: 10.1159/000542956. eCollection 2025 Jan-Dec.
5
Retinal Focal Nodular Gliosis (Vasoproliferative Tumors) Have Varied Clinical Courses Requiring Tailored Management: A Case Series.视网膜局灶性结节性胶质增生症(血管增生性肿瘤)具有多样的临床病程,需要个体化管理:病例系列
Ocul Oncol Pathol. 2024 Sep;10(3):175-181. doi: 10.1159/000538984. Epub 2024 May 20.
6
Vasoproliferative Tumor Secondary to Sarcoidosis-Associated Intermediate Uveitis.结节病相关性中间葡萄膜炎继发的血管增生性肿瘤
Turk J Ophthalmol. 2024 Apr 19;54(2):108-111. doi: 10.4274/tjo.galenos.2024.36926.
7
Vitrectomy and tumor endoresection for the diagnosis and treatment of focal nodular retinal gliosis.玻璃体切除术和肿瘤内切除术用于局灶性结节性视网膜神经胶质增生的诊断和治疗。
Digit J Ophthalmol. 2023 Sep 30;29(3):83-87. doi: 10.5693/djo.02.2023.07.004. eCollection 2023.
8
Retinal vasoproliferative tumor regression after intravitreal aflibercept.玻璃体内注射阿柏西普后视网膜血管增生性肿瘤消退
Taiwan J Ophthalmol. 2022 May 30;13(2):249-252. doi: 10.4103/tjo.tjo_21_22. eCollection 2023 Apr-Jun.
9
Multimodal imaging of reactive retinal astrocytic vasoproliferative tumour in a case of systemic tuberculosis.全身性结核病例中反应性视网膜星形细胞血管增生性肿瘤的多模态成像。
BMJ Case Rep. 2023 Jan 10;16(1):e244642. doi: 10.1136/bcr-2021-244642.
10
Noninvasive Imaging of a Vasoproliferative Retinal Tumor Treated with Cryopexy.冷冻治疗的视网膜血管增生性肿瘤的无创成像
Case Rep Ophthalmol. 2022 Aug 16;13(2):611-616. doi: 10.1159/000525939. eCollection 2022 May-Aug.